Literature DB >> 32718542

Small Cell Cancer Transformation of Lung Adenocarcinoma During Durvalumab Treatment After Chemoradiotherapy.

Sayaka Arakawa1, Tatsuya Yoshida2, Yuko Nakayama3, Noriko Motoi4, Yuichiro Ohe1.   

Abstract

Entities:  

Year:  2020        PMID： 32718542     DOI： 10.1016/j.jtho.2019.12.117

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach.

Authors:  Elisa Baldelli; Martina Mandarano; Guido Bellezza; Emanuel F Petricoin; Mariaelena Pierobon
Journal:  Cell Rep Methods       Date:  2022-08-22

2.  Case Report: Re-Sensitization to Gefitinib in Lung Adenocarcinoma Harboring EGFR Mutation and High PD-L1 Expression After Immunotherapy Resistance, Which Finally Transform Into Small Cell Carcinoma.

Authors:  Xiaoqian Zhai; Jiewei Liu; Zuoyu Liang; Zhixi Li; Yanyang Liu; Lin Huang; Weiya Wang; Feng Luo
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.